Cytotoxic enhancement of low dose-rate irradiation in human lung cancer cells by mild hyperthermia

被引:0
|
作者
Sakurai, H [1 ]
Hasuhashi, N [1 ]
Kitamoto, Y [1 ]
Nonaka, T [1 ]
Harashima, K [1 ]
Higuchi, K [1 ]
Muramatsu, H [1 ]
Ebara, T [1 ]
Ishikawa, H [1 ]
Niibe, H [1 ]
机构
[1] Gunma Univ, Sch Med, Dept Radiol & Radiat Oncol, Maebashi, Gumma 3718511, Japan
关键词
mild hyperthermia; radiation; low dose-rate irradiation; human cancer cell line;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The aim of this study was to investigate the cell killing induced by low dose-rate irradiation (LDRI) simultaneously combined with long duration mild hyperthermia in LK87 human lung cancer cells. Cell cycle alteration due to this combined treatment was also observed Materials and Methods: Human lung adenocarcinoma cells, LK87, were treated with concurrent LDRI (50 cGy/hr) and mild hyperthermia (38 to 42 degrees C). Cell survival was estimated by clonogenic assay. Flow cytometry was performed with FACScan. The treatments were simultaneously performed for up to 48 hr (24 Gy). Results: Survival curves of mild hyperthermia alone revealed development of chronic thermotolerance up to 48 hr, whereas LDRI plus hyperthermia caused an exponential decrease in survival. The LDRI cytotoxicities were enhanced by mild hyperthermia over a non-lethal temperature range. The Do values calculated from dose response curves at 37, 38, 39, 40, 41 41.5 and 42 degrees C were 6.55, 5.25, 4.24, 3.99, 3.46, 1.83 and 0.70 Gy, respectively. Cell cycle analysis demonstrated a remarkable G2 and a mild G1 block for LDRI alone but only a GI block was observed for LDRI combined with 41 degrees C hyperthermia. Conclusion: The LDRI cytotoxicity was enhanced by long duration mild temperature hyperthermia. The suppression of chronic thermotolerance was considered to be a mechanism involved in this sensitization.
引用
收藏
页码:2525 / 2528
页数:4
相关论文
共 50 条
  • [31] MODERATE HYPERTHERMIA AND LOW-DOSE RATE IRRADIATION
    LING, CC
    ROBINSON, E
    RADIATION RESEARCH, 1988, 114 (02) : 379 - 384
  • [32] Interactions of mild hyperthermia, cisplatin and split dose irradiation in human ovarian carcinoma cells
    G. P. Raaphorst
    J. Miao
    D. Stewart
    C. E. Ng
    Cancer Chemotherapy and Pharmacology, 1998, 41 : 491 - 496
  • [33] Interactions of mild hyperthermia, cisplatin and split dose irradiation in human ovarian carcinoma cells
    Raaphorst, GP
    Miao, J
    Stewart, D
    Ng, CE
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1998, 41 (06) : 491 - 496
  • [34] RESPONSE OF HEMATOPOIETIC STROMAL PROGENITOR CELLS IN MOUSE MARROW TO LOW DOSE-RATE IRRADIATION
    WANG, SB
    HENDRY, JH
    TESTA, NG
    BRITISH JOURNAL OF RADIOLOGY, 1984, 57 (683): : 1053 - 1053
  • [35] Inverse dose-rate effect due to pre-mitotic accumulation during continuous low dose-rate irradiation of cervix carcinoma cells
    Furre, T
    Koritzinsky, M
    Olsen, DR
    Pettersen, EO
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 1999, 75 (06) : 699 - 707
  • [36] PROPHYLACTIC VAGINAL IRRADIATION WITH LOW DOSE-RATE AFTERLOADING TECHNIQUE IN WOMEN WITH ENDOMETRIAL CANCER
    PETTERSSON, B
    JANSSON, H
    NILSSON, A
    SCHMIDT, M
    STENSON, S
    BRACHYTHERAPY 2, 1989, : 240 - 244
  • [37] Differential responses of stress genes to low dose-rate γ irradiation
    Amundson, SA
    Lee, RA
    Koch-Paiz, CA
    Bittner, ML
    Meltzer, P
    Trent, JM
    Fornace, AJ
    MOLECULAR CANCER RESEARCH, 2003, 1 (06) : 445 - 452
  • [38] IRRADIATION DOSE-RATE DEPENDENT SURVIVAL OF HUMAN-BONE MARROW STROMAL CELLS
    FITZGERALD, TJ
    ROTHSTEIN, L
    DAUGHERTY, C
    KASE, K
    GREENBERGER, JS
    CLINICAL RESEARCH, 1985, 33 (03): : A760 - A760
  • [39] THE RESPONSE OF A SOLID TUMOR TO X-IRRADIATION AS MODIFIED BY DOSE-RATE, FRACTIONATION, AND HYPERTHERMIA
    BAKER, DG
    SAGER, HT
    CONSTABLE, WC
    CANCER INVESTIGATION, 1987, 5 (05) : 409 - 416
  • [40] Low dose-rate irradiation with [3H]-labelled valine to selectively target hypoxic cells in a human colorectal cancer xenograft model
    Mikalsen, Stine Gyland
    Mikalsen, Lars Tore Gyland
    Sandvik, Joe Alexander
    Aarnes, Eva-Katrine
    Fenne, Siri
    Flatmark, Kjersti
    Lyng, Heidi
    Edin, Nina Frederike Jeppesen
    Pettersen, Erik Olai
    ACTA ONCOLOGICA, 2018, 57 (09) : 1216 - 1224